Adult brainstem gliomas

Oncologist

Volumn 17, Issue 3, 2012, Pages 388-397

  Reyes Botero, German ^a,c,d,e   Mokhtari, Karima ^b,c,d,e   Martin Duverneuil, Nadine ^b   Delattre, Jean Yves ^a,c,d,e   Laigle Donadey, Florence ^a,c,d,e  

^a Service de Neurologie 2 Division Mazarin   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSERM   (France)

^e CNRS   (France)

Author keywords

Adults; Brainstem glioma; Classification; MRI; Treatment

Indexed keywords

BEVACIZUMAB; GLUCOCORTICOID; IRINOTECAN; NITROSOUREA; PLATINUM DERIVATIVE; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; ARTICLE; ASTROCYTOMA; BIOPSY; BRAIN STEM GLIOMA; DIFFUSE INTRINSIC LOW GRADE BRAIN STEM GLIOMA; ENHANCING MALIGNANT BRAIN STEM GLIOMA; EXOPHYTIC BRAIN STEM GLIOMA; FOCAL TECTAL BRAIN STEM GLIOMA; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE OF ONSET; BRAIN STEM NEOPLASMS; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PROGNOSIS;

EID: 84859387473     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0335     Document Type: Article

References (64)

1. Barkovich AJ, Krischer J, Kun LE et al. Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 1990; 16:73-83.
2. Donaldson SS, Laningham F, Fisher P et al. Advances toward an understanding of brainstem gliomas. J Clin Oncol 2006;24:1266-1272.
3. Fischbein NJ, Prados MD, Wara W et al. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 1996;24:9-23.
4. Guillamo JS, Monjour A, Taillandier L et al. Brainstem gliomas in adults: prognostic factors and classification. Brain 2001;124:2528-2539.
5. Landolfi JC, Thaler HT, DeAngelis LM. Adult brainstem gliomas. Neurology 1998;51:1136-1139.
6. Grill J, Puget S, Andreiuolo F et al. Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma. Pediatr Blood Cancer 2011; doi: 10.1002/pbc.24060 [Epub ahead of print].
7. Shumacher M, Schulte-Monting J, Stoeter P et al. Magnetic resonance imaging compared with biopsy in the diagnosis of brainstem diseases of childhood: a multicenter review. J Neurosurg 2007;106(2 Suppl):111-119.
8. Salmaggi A, Fariselli L, Milanesi I et al. Natural history and management of brainstem gliomas in adults: a retrospective Italian study. J Neurol 2008; 255:171-177.
9. Rineer J, Schreiber D, Choi K et al. Characterization and outcomes of infratentorial malignant glioma: a population-based study using the Surveillance Epidemiology and End-Results database. Radiother Oncol 2010;95:321-326.
10. Martin-Duverneuil N, Mothkari K. Gliomes du tronc cérébral. In: Martin-Duverneuil N, Mothkari K, eds. Les tumeurs intracraniennes de l'adulte, First edition. Paris: Sauramps Medical editorial, 2009: 114-116.
11. Kesari S, Kim RS, Markos V et al. Prognostic factors in adult brainstem gliomas: a multicenter, retrospective analysis of 101 cases. J Neurooncol 2008; 88:175-183.
12. Guillamo JS, Doz F, Delattre JY. Brain stem gliomas. Curr Opin Neurol 2001;14:711-715.
13. Broniscer A, Baker J, Baker S et al. Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer 2010; 116:4632-4637.
14. Selvapandian S, Rajshekhar V, Chandy MJ. Brainstem glioma: comparative study of clinicoradiological presentation, pathology and outcome in children and adults. Acta Neurochir (Wien) 1999; 141:721-726; discussion 726-727.
15. Marin-Sanabria EA, Kobayashi N, Miyake S et al. Snoring associated with Ondine's curse in a patient with brainstem glioma. J Clin Neurosci 2006; 13:370-373.
16. Gaviani P, Gonzalez R, Zhu J. Brainstem glioma central neurogenic hyperventilation and lactate production. Neurology 2005;64:166.
17. Saka E, Ozkaynak S, Tuncer R. Tongue tremor in brainstem pilocytic astrocytoma. J Clin Neurosci 2006;13:503-506.
18. Yoshimura M, Yamamoto T, Iso-o N et al. Hemiparkinsonism associated with a mesencephalic tumor. J Neurol Sci 2002;197:89-92.
19. Lim EC, Wilder-Smith EP, Chong JL et al. Seeing the light: brainstem glioma causing visual auras and migraine. Cephalalgia 2005;25:154-156.
20. Ikeda K, Baba S, Iwasaki Y. Pseudomyasthenia in a patient with pontine glioma. Clin Neurol Neurosurg 2006;108:809-810.
21. Alvarez-Linera J. Magnetic resonance techniques for the brainstem. Semin Ultrasound CT MR 2010;31:230-245.
22. Panigrahy A, Nelson M, Finlay J et al. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro-Oncology 2008;10:32-44.
23. Porto L, Hattingen E, Pilatus U et al. Proton magnetic resonance spectroscopy in childhood brainstem lesions. Childs Nerv Syst 2007;23:305-314.
24. Giussani C, Poliakov A, Ferri RT. DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma. NeuroImage 2010;52: 217-223.
25. Kiyosue H, Tanoue S, Sagara Y. The anterior medullary-anterior pontomesencephalic venous system and its bridging veins communicating to the dural sinuses: normal anatomy and drainage routes from dural arteriovenous fistulas. Neuroradiology 2008;50:1013-1023.
26. Guillamo JS, Créange A, Kalifa C et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 2003;126:152-160.
27. Ullrich NJ, Raja AI, Irons MB et al. Brainstem lesions in neurofibromatosis type 1. Neurosurgery 2007;61:762-766.
28. Piette C, Munaut C, Foidart JM. Treating gliomas with glucocorticoids: from bedside to bench. Acta Neuropathol 2006;112:651-664.
29. Mursch K, Halatsch ME, Markakis E et al. Intrinsic brainstem tumours in adults: results of microneurosurgical treatment of 16 consecutive patients. Br J Neurosurg 2005;19:128-136.
30. Tanaka S, Kobayashi I, Utsuki S et al. Biopsy of brain stem glioma using motor-evoked potential mapping by direct peduncular stimulation and individual adjuvant therapy. Case report. Neurol Med Chir (Tokyo) 2005;45:49-55.
31. Rachinger W, Grau S, Holtmannspotter M et al. Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only. J Neurol Neurosurg Psychiatry 2009;80: 1134-1139.
32. Reithmeier T, Kuzeawu A, Berger H et al. Adult brainstem gliomas: a retrospective analysis of 110 cases within the German Glioma Network 60th Annual Meeting of the German Society of Neurosurgery (DGNC); May 24-27, 2009; Munster, Germany.
33. Hankinson TC, Campagna EJ, Forem NK et al. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons. J Neurosurg Pediatr 2011;8:97-102.
34. Mandell LR, Kadota R, Freeman C et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 1999;43:959-964.
35. Gururangan S, McLaughlin CA, Brashears J et al. Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma. J Neurooncol 2006;77:207-212.
36. Stark AM, Maslehaty H, Hugo HH et al. Glioblastoma of the cerebellum and brainstem. J Clin Neurosci 2010;17:1248-125130.
37. Kwon J, Kim I, Cheon J et al. Paediatric brainstem gliomas: MRI, FDG-PET and histological grading correlation. Pediatr Radiol 2006;36:959-964.
38. Rajshekhar V, Chandy MJ. Computerized tomography-guided stereotactic surgery for brainstem masses: a risk-benefit analysis in 71 patients. J Neurosurg 1995;82:976-981.
39. Boviatsis EJ, Kouyialis AT, Stranjalis G et al. CT-guided stereotactic biopsies of brain stem lesions: personal experience and literature review. Neurol Sci 2003;24:97-102.
40. Friedman WA, Sceats J, Nestok B et al. The incidence of unexpected pathological findings in an image-guided biopsy series: a review of 100 consecutive cases. Neurosurgery 1989;25:180-184.
41. Gonçalves-Ferreira AJ, Herculano-Carvalho M, Pimentel J. Stereotactic biopsies of focal brainstem lesions. Surg Neurol 2003;60:311-320.
42. Swinson BM, Friedman W, Yachnis AT. Pontine atypical neurocytoma: cAse report. Neurosurgery 2006;58:E990.
43. Shenoy SN, Raja A. Cystic trochlear nerve neurinoma mimicking intrinsic brainstem tumour. Br J Neurosurg 2004;18:183-186.
44. Massager N, David P, Goldman S et al. Combined magnetic resonance imaging-and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg 2000;93:951-957.
45. Pirotte JM, Luba A, Massager N et al. Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors. J Neurosurg Pediatr 2010;5:486-499.
46. Mehta VS, Chandra PS, Pankaj Kumar Singh et al. Surgical considerations for 'intrinsic' brainstem gliomas: proposal of a modification in classification. Neurol India 2009;57:274-281.
47. Abernathey CD, Camacho A, Kelly PJ. Stereotaxic suboccipital transcerebellar biopsy of pontine mass lesions. J Neurosurg 1989;70:195-200.
48. Fuchs I, Kreil W, Sutter B et al. Gamma knife radiosurgery of brainstem gliomas. Acta Neurochir Suppl 2002;84:85-90.
49. Zhang C, Yao Y, Wang Y et al. Temozolomide for adult brain stem glioblastoma: case report of a long-term survivor. Int J Neurosci 2010;120:787-791.
50. Torcuator R, Zuniga R, Loutfi R et al. Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report. J Neurooncol 2009;93:409-412.
51. Raza S, Donach M. Bevacizumab in adult malignant brainstem gliomas. J Neurooncol 2009;95: 299-300.
52. Gururangan S, Chi S, Poussaint TY et al. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a pediatric brain tumor consortium study. J Clin Oncol 2010;28:3069-3075.
53. Hamilton MG, Lauryssen C, Hagen N. Focal midbrain glioma: long term survival in a cohort of 16 patients and the implications for management. Can J Neurol Sci 1996;23:204-207.
54. Bowers DC, Georgiades C, Aronson LJ et al. Tectal gliomas: natural history of an indolent lesion in pediatric patients. Pediatr Neurosurg 2000;32:24-29.
55. Dǎlioǧlu E, Cataltepe O, Akalan N. Tectal gliomas in children: the implications for natural history and management strategy. Pediatr Neurosurg 2003;38:223-231.
56. Chaddad Neto F, Lopes A, Alberto Filho M et al. Tectal glioblastoma. Arq Neuropsiquiatr 2007; 65:996-999.
57. Oka F, Yamashita Y, Kumabe T et al. Total resection of a hemorrhagic tectal pilocytic astrocytomacase report. Neurol Med Chir (Tokyo) 2007;47: 219-221.
58. Lee T, Galarza M, Petito C et al. Exophytic malignant brainstem mixed glioma in an adult. J Neurooncol 1998;37:123-129.
59. Luetjens G, Mirzayan MJ, Brandis A et al. Exophytic giant cell glioblastoma of the medulla oblongata. J Neurosurg 2009;110:589-593.
60. Swaroop GR, Whittle IR. Exophytic pontine glioblastoma mimicking acoustic neuroma. J Neurosurg Sci 1997;41:409-411.
61. Fouladi M, Nicholson HS, Zhou T et al. A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study. Cancer 2007;110: 2535-2541.
62. Pollack IF, Jakacki RI, Blaney SM et al. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro Oncol 2007;9:145-160.
63. Pollack IF, Stewart CF, Kocak M et al. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol 2011;13:290-297.
64. Linstadt DE, Edwards MS, Prados M et al. Hyperfractionated irradiation for adults with brainstem gliomas. Int J Radiat Oncol Biol Phys 1991;20: 757-760.